115
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

Eccrine Poroma with Concurrent Basal Cell Carcinoma: A Rare Combination

ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon
Pages 2965-2970 | Received 11 Aug 2023, Accepted 30 Sep 2023, Published online: 20 Oct 2023

References

  • Miller AC, Adjei S, Temiz LA, et al. Dermal duct tumor: a diagnostic dilemma. Dermatopathology. 2022;9(1):36–47. doi:10.3390/dermatopathology9010007
  • Wollina U, Castelli E, Rülke D. Immunohistochemistry of eccrine poroma and porocarcinoma--more than acrosyringeal tumors? Recent results in cancer research. Fortschritte Der Krebsforschung. 1995;1995:139303–139316.
  • Hasan A, Nafie K, Monazea K, et al. A rare case of recurrent eccrine poroma underlying gluteal abscess. Int J Surg Case Rep. 2020;75:7529–7531.
  • Cohen PR, Calame A. Multiple Skin Neoplasms at One Site (MUSK IN A NEST): a comprehensive review of basal cell carcinoma and benign or malignant “collision” tumors at the same cutaneous location. Clin Cosmet Investig Dermatol. 2020;13:731–741. doi:10.2147/CCID.S259324
  • AliFuat C, Andac A, Abdulkerim Y, et al. Nevus sebaceus with basal cell carcinoma, poroma, and verruca vulgaris. Indian J Pathol Microbiol. 2015;58(4):534. doi:10.4103/0377-4929.168885
  • Goldman P, Pinkus H, Rogin JR. Eccrine poroma; tumors exhibiting features of the epidermal sweat duct unit. AMA Arch Derm. 1956;74(5):511–521. doi:10.1001/archderm.1956.01550110055013
  • Sekine S, Kiyono T, Ryo E, et al. Recurrent YAP1-MAML2 and YAP1-NUTM1 fusions in poroma and porocarcinoma. J Clin Invest. 2019;129(9):3827–3832. doi:10.1172/JCI126185
  • Sidro-Sarto M, Guimerá-Martin-Neda F, Perez-Robayna N, et al. Eccrine poroma arising in chronic radiation dermatitis. J Eur Acad Dermatol Venereol. 2008;22(12):1517–1519. doi:10.1111/j.1468-3083.2008.02695.x
  • Nemoto I, Akiyama M, Aoyagi S, Nomura T, Shimizu H. Eccrine porocarcinoma and eccrine poroma arising in a scar. Br J Dermatol. 2004;150(6):1232–1233. doi:10.1111/j.1365-2133.2004.05997.x
  • Albert B, Mauricio G, Llúcia A, et al. The challenging diagnosis of eccrine poromas. J Am Acad Dermatol. 2016;74(6):e113–e115. doi:10.1016/j.jaad.2015.11.046
  • Robson A, Greene J, Ansari N, et al. Eccrine Porocarcinoma (Malignant Eccrine Poroma). Am J Surg Pathol. 2001;25(6):710–720. doi:10.1097/00000478-200106000-00002
  • Watanabe S, Mogi S, Ichikawa E, et al. Immunohistochemical analysis of keratin distribution in eccrine poroma. Am J Pathol. 1993;142(1):231–239.
  • Corrêa AMDA, Ré LMRD, Bartoli MLD, et al. Pigmented eccrine poroma in an atypical location. An Bras Dermatol. 2022;97(5):624–627. doi:10.1016/j.abd.2021.10.006
  • Crowson AN. Basal cell carcinoma: biology, morphology and clinical implications. Mod Pathol. 2006;19:S127–S147.
  • Tanese K. Diagnosis and management of basal cell carcinoma. Curr Treat Options Oncol. 2019;20(2). doi:10.1007/s11864-019-0610-0
  • Hanke CW, Temofeew RK. Basal cell carcinoma with eccrine differentiation (Eccrine Epithelioma). J Dermatol Surg Oncol. 1986;12(8):820–824. doi:10.1111/j.1524-4725.1986.tb01988.x
  • Misago N, Satoh T, Narisawa Y. Basal cell carcinoma with ductal and glandular differentiation: a clinicopathological and immunohistochemical study of 10 cases. Euro J Dermatol. 2004;14(6):383–387.
  • Ansai SI, Takayama R, Kimura T, Kawana S. Ber-EP4 is a useful marker for follicular germinative cell differentiation of cutaneous epithelial neoplasms. J Dermatol. 2012;39(8):688–692. doi:10.1111/j.1346-8138.2011.01494.x
  • Afshar M, Deroide F, Robson A. BerEP4 is widely expressed in tumors of the sweat apparatus: a source of potential diagnostic error. J Cutan Pathol. 2012;40(2):259–264. doi:10.1111/cup.12043
  • Iljin A, Stasikowska-Kanicka O, Zieliński T, et al. Immunoexpression of Bmi-1, CK15, Bcl-2 in different types of basal cell carcinomas. Adv DermatolAllergol. 2022;39(5):980–985. doi:10.5114/ada.2022.120888
  • Astarci HM, Gurbuz GA, Sengul D, et al. Significance of androgen receptor and CD10 expression in cutaneous basal cell carcinoma and trichoepithelioma. Oncol Lett. 2015;10(6):3466–3470. doi:10.3892/ol.2015.3804
  • García-de-la-Fuente MR, Santacana M, Valls J, et al. Cytokeratin profile of basal cell carcinomas according to the degree of sun exposure and to the anatomical localization. Am J Dermatopathol. 2018;40(5):342–348. doi:10.1097/DAD.0000000000001042
  • Evangelista MTP, North JP. Comparative analysis of cytokeratin 15, TDAG51, cytokeratin 20 and androgen receptor in sclerosing adnexal neoplasms and variants of basal cell carcinoma. J Cutan Pathol. 2015;42(11):824–831. doi:10.1111/cup.12546